UbiVac
Home Collaboration Contact
New Index
Overview Executive Leadership Advisory Board
Technologies Pipeline Clinical Trials
Presentations Publications Press Releases In the News
Home About Overview Executive Leadership Advisory Board Research & Pipeline Technologies Pipeline Clinical Trials Collaboration Newsroom Presentations Publications Press Releases In the News Contact
UbiVac
New Index

Adoptive TIL in HPV-negative Oral SCCA

Rom Leidner, Brendan D Curti, Roxanne M Payne, Walter Urba, Keith S Bahjat, Yoshinobu Koguchi, Krista Nelson, Jennifer A Moore, Marka Crittenden, Yedeh Ying, Ashish Patel, Allen Cheng, Tuan G Bui, Traci Hilton, Christopher Paustian, Sachin Puri, Hong Ming Hu, Carlo Bifulco, Zipei Feng, R Bryan Bell and Bernard Fox

Journal for ImmunoTherapy of Cancer, Vol 3, Suppl 2, November 4, 2015

Bernie FoxJune 4, 2018
Facebook0 Twitter 0 Likes
Previous

Preliminary Analysis of Immune Responses in Patients Enrolled in a Phase II Trial of Cyclophosphamide with Allogenic DRibble Vaccine Alone (DPV-001) or with GM-CSF or Imiquimod

Bernie FoxJune 4, 2018
Next

Cross-presentation of Viral Antigens in DRibbles Leads to Efficient Activation of Virus-specific Human Memory T Cells

Bernie FoxJune 4, 2018

© 2018 UbiVac | All rights reserved.